Pre-market
You're reading the free version. Trader adds the live tape and alerts. Start tracking

1 trade

Disclosure transactions for Telix Pharmaceuticals Ltd
Reporting person Filed Transaction Transaction value Source Actions
Smith Darren Charlton Group Chief Financial Officer Sep 14, 2026 7-day lag Buy Sep 7, 2026 $20K Filed shares x price SEC Form 4 View filing
Smith Darren Charlton Group Chief Financial Officer
Buy
Calculated transaction value
$20K 2,071 shares @ $9.66
Traded
Sep 7, 2026
Filed
Sep 14, 2026